Pancreatic Cancer Research

ResearcherAffiliated Hospital of Guizhou Medical UniversityNo recent work listed

Jichuan Xu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5061804758. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: 3 papers

Papers 4

  1. KIF15 is essential for USP10-mediated PGK1 deubiquitination during the glycolysis of pancreatic cancer. Co-author DOI 10.1038/s41419-023-05679-2↗
  2. USP33 promotes pancreatic cancer malignant phenotype through the regulation of TGFBR2/TGFβ signaling pathway. Co-author DOI 10.1038/s41419-023-05871-4↗
  3. VSIG2 promotes malignant progression of pancreatic ductal adenocarcinoma by enhancing LAMTOR2-mediated mTOR activation. Co-author DOI 10.1186/s12964-023-01209-x↗
  4. The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer. Co-author DOI 10.1038/s41420-022-01061-x↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianxin Jiang · 4 shared papers, 2022–2023 · strength 0.95
  2. Xinyuan Liu · 3 shared papers, 2022–2023 · strength 0.68
  3. Gang Quan · 2 shared papers, 2023 · strength 0.48
  4. Jian Xu · 2 shared papers, 2022–2023 · strength 0.46
  5. Jie Wang · 1 shared paper, 2023 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.